搜索临床试验以:肝素
总计1104个结果
-
National Institute of Neurological Disorders and...完全的
-
University Hospital, AkershusVestre Viken Hospital Trust; University of Oslo; Asker & Baerum Hospital; Sykehuset Innlandet HF未知
-
Sun Yat-sen UniversityEli Lilly and Company; Ministry of Health, China; Amylin Pharmaceuticals, LLC.完全的
-
First Affiliated Hospital of Zhejiang UniversityZhejiang University完全的
-
Bayer完全的
-
Children's Hospital Medical Center, CincinnatiNational Institute of Neurological Disorders and Stroke (NINDS)完全的
-
University of Southern CaliforniaNational Cancer Institute (NCI); Celgene Corporation终止
-
World Health OrganizationLondon School of Hygiene and Tropical Medicine; University of Ghana; Biomedical Research and Training... 和其他合作者招聘中
-
Kaiser PermanenteNational Institute on Aging (NIA); National Center for Complementary and Integrative Health...未知
-
Astellas Pharma Inc完全的肾移植比利时, 法国, 意大利, 瑞典, 瑞士, 西班牙, 葡萄牙, 俄罗斯联邦, 德国, 大韩民国, 捷克语, 斯洛伐克, 澳大利亚, 匈牙利, 荷兰, 罗马尼亚, 爱沙尼亚, 拉脱维亚, 墨西哥, 立陶宛, 波兰, 哥伦比亚, 芬兰, 挪威
-
St. Luke's-Roosevelt Hospital CenterThe Zucker Hillside Hospital撤销
-
Fred Hutchinson Cancer CenterHighPass Bio, Inc.暂停急性髓性白血病 | 白血病 | 慢性粒单核细胞白血病 | 幼年型粒单核细胞白血病 | 急性淋巴细胞白血病 | 慢性粒细胞白血病 | 骨髓增生异常综合症 | 复发性急性髓性白血病 | 复发性慢性粒单核细胞白血病 | 复发性骨髓增生异常综合征 | 难治性骨髓增生异常综合征 | 复发性儿童急性淋巴细胞白血病 | 复发性儿童急性髓性白血病 | 难治性成人急性淋巴细胞白血病 | 母细胞期慢性粒细胞白血病,BCR-ABL1 阳性 | 复发性急性淋巴细胞白血病 | 复发性慢性粒细胞白血病,BCR-ABL1 阳性 | 难治性急性淋巴细胞白血病 | 难治性慢性粒细胞白血病,BCR-ABL1 阳性 | 最小残留病 | 复发性混合表型急性白血病 | 急性未分化白血病 | 急性双表型白血病 | 复发性急性双表型白血病 | 复发性母细胞性浆细... 及其他条件美国
-
University of MelbourneAustralian and New Zealand Intensive Care Research Centre; The Peter Doherty Institute for Infection... 和其他合作者主动,不招人
-
Boston Scientific CorporationEKOS Corporation撤销
-
National Institute of Allergy and Infectious Diseases...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Clinical Islet Transplantation...完全的
-
First Affiliated Hospital of Chongqing Medical...Southwest Hospital, China; Central South University; The Second Affiliated Hospital of Chongqing... 和其他合作者招聘中
-
Hyunseok Kang, MDNRG Oncology完全的临床 IV 期 HPV 介导的(p16 阳性)口咽癌 AJCC v8 | III 期下咽癌 AJCC v8 | III 期喉癌 AJCC v8 | III 期唇癌和口腔癌 AJCC v8 | III 期口咽(p16 阴性)癌 AJCC v8 | IV 期下咽癌 AJCC v8 | IV 期喉癌 AJCC v8 | IV 期唇部和口腔癌 AJCC v8 | IV 期口咽(p16 阴性)癌 AJCC v8 | IVA 期唇部和口腔癌 AJCC v8 | 病理学 III 期 HPV 介导的(p16 阳性)口咽癌 AJCC v8 | 病理学 IV 期 HPV 介导的(p16 阳性)口咽癌 AJCC v8 | IVA 期下咽癌 AJCC v8 | IVA 期喉癌... 及其他条件美国
-
National Cancer Institute (NCI)完全的Trebananib 联合或不联合 Bevacizumab、Pazopanib Hydrochloride、Sorafenib Tosylate 或 Sunitinib Malate 治疗晚期肾癌患者晚期肾细胞癌 | III 期肾细胞癌 AJCC v7 | IV 期肾细胞癌 AJCC v7 | 晚期肉瘤样肾细胞癌美国
-
National Institute of Allergy and Infectious Diseases...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)不再可用
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Medical Research Council完全的
-
Uma Borate暂停